Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

H.J. Meulenbeld; E.D. van Werkhoven; J.L.L.M. Coenen; G.J. Creemers; O.J.L. Loosveld; P.C. de Jong; A.J. ten Tije; S.D. Fossa; M. Polee; W.R. Gerritsen; O. Dalesio; R. de Wit

doi:10.1016/j.ejca.2012.05.014

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

H.J. Meulenbeld, E.D. van Werkhoven, J.L.L.M. Coenen, G.J. Creemers, O.J.L. Loosveld, P.C. de Jong, A.J. ten Tije, S.D. Fossa, M. Polee, W.R. Gerritsen, O. Dalesio, R. de Wit

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2993-3000
Journal	European Journal of Cancer
Volume	48
Issue number	16
DOIs	https://doi.org/10.1016/j.ejca.2012.05.014
Publication status	Published - 2012

Access to Document

10.1016/j.ejca.2012.05.014

Cite this

Meulenbeld, H. J., van Werkhoven, E. D., Coenen, J. L. L. M., Creemers, G. J., Loosveld, O. J. L., de Jong, P. C., ten Tije, A. J., Fossa, S. D., Polee, M., Gerritsen, W. R., Dalesio, O., & de Wit, R. (2012). Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). European Journal of Cancer, 48(16), 2993-3000. https://doi.org/10.1016/j.ejca.2012.05.014

@article{0d40afeadd1548d780669b1c7aa93d8b,

title = "Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)",

author = "H.J. Meulenbeld and {van Werkhoven}, E.D. and J.L.L.M. Coenen and G.J. Creemers and O.J.L. Loosveld and {de Jong}, P.C. and {ten Tije}, A.J. and S.D. Fossa and M. Polee and W.R. Gerritsen and O. Dalesio and {de Wit}, R.",

year = "2012",

doi = "10.1016/j.ejca.2012.05.014",

language = "Undefined/Unknown",

volume = "48",

pages = "2993--3000",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Pergamon",

number = "16",

}

Meulenbeld, HJ, van Werkhoven, ED, Coenen, JLLM, Creemers, GJ, Loosveld, OJL, de Jong, PC, ten Tije, AJ, Fossa, SD, Polee, M, Gerritsen, WR, Dalesio, O & de Wit, R 2012, 'Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)', European Journal of Cancer, vol. 48, no. 16, pp. 2993-3000. https://doi.org/10.1016/j.ejca.2012.05.014

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). / Meulenbeld, H.J.; van Werkhoven, E.D.; Coenen, J.L.L.M. et al.

In: European Journal of Cancer, Vol. 48, No. 16, 2012, p. 2993-3000.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

AU - Meulenbeld, H.J.

AU - van Werkhoven, E.D.

AU - Coenen, J.L.L.M.

AU - Creemers, G.J.

AU - Loosveld, O.J.L.

AU - de Jong, P.C.

AU - ten Tije, A.J.

AU - Fossa, S.D.

AU - Polee, M.

AU - Gerritsen, W.R.

AU - Dalesio, O.

AU - de Wit, R.

PY - 2012

Y1 - 2012

U2 - 10.1016/j.ejca.2012.05.014

DO - 10.1016/j.ejca.2012.05.014

M3 - Article

C2 - 22677260

VL - 48

SP - 2993

EP - 3000

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 16

ER -